Evidence map›Paper›PMID 37570594›Full record

ReviewMolecules (Basel, Switzerland)2023

Phytochemical Properties, Extraction, and Pharmacological Benefits of Naringin: A Review.

V S Shilpa, Rafeeya Shams, Kshirod Kumar Dash, Vinay Kumar Pandey, Aamir Hussain Dar, Shaikh Ayaz Mukarram, Endre Harsányi, Béla Kovács

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed, 1 pooled it
24.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 1 synthesis or guideline pooled it, 161 citations in OpenAlex.

  1. Pooled it
  2. Enzyme promiscuity-driven co-production of flavonoid 7-Synthetic and systems biotechnology · 2026
    Article
  3. Article
  4. Processing Methods ofFoods (Basel, Switzerland) · 2026
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Dual action of herbal compounds inFrontiers in immunology · 2026
    Review
  20. Article

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

V S ShilpaDepartment of Food Technology & Nutrition, Lovely Professional University, Phagwara 144001, Punjab, India.
Rafeeya ShamsDepartment of Food Technology & Nutrition, Lovely Professional University, Phagwara 144001, Punjab, India.
Kshirod Kumar DashDepartment of Food Processing Technology, Ghani Khan Choudhury Institute of Engineering and Technology Malda, Malda 732141, West Bengal, India.ORCID 0000-0002-3875-1286
Vinay Kumar PandeyDepartment of Bioengineering, Integral University, Lucknow 226026, Uttar Pradesh, India.ORCID 0000-0001-9818-5805
Aamir Hussain DarDepartment of Food Technology, Islamic University of Science and Technology, Awantipora 192122, Kashmir, India.
Shaikh Ayaz MukarramFaculty of Agriculture, Food Science and Environmental Management Institute of Food Science, University of Debrecen, 4032 Debrecen, Hungary.ORCID 0000-0002-0410-5286
Endre HarsányiFaculty of Agriculture, Food Science and Environmental Management, Institute of Land Utilization, Engineering and Precision Technology, University of Debrecen, 4032 Debrecen, Hungary.
Béla KovácsFaculty of Agriculture, Food Science and Environmental Management Institute of Food Science, University of Debrecen, 4032 Debrecen, Hungary.ORCID 0000-0002-6439-4753
University of Debrecen · HULovely Professional University · INIntegral University · INIslamic University of Science and Technology · INMalda Medical College and Hospital · IN

Funding

National Research, Development and Innovation Fund of Hungary TKP2021-NKTA-32
6 · The paper itself

Abstract

This review describes the various innovative approaches implemented for naringin extraction as well as the recent developments in the field. Naringin was assessed in terms of its structure, chemical composition, and potential food sources. How naringin works pharmacologically was discussed, including its potential as an anti-diabetic, anti-inflammatory, and hepatoprotective substance. Citrus flavonoids are crucial herbal additives that have a huge spectrum of organic activities. Naringin is a nutritional flavanone glycoside that has been shown to be effective in the treatment of a few chronic disorders associated with ageing. Citrus fruits contain a common flavone glycoside that has specific pharmacological and biological properties. Naringin, a flavone glycoside with a range of intriguing characteristics, is abundant in citrus fruits. Naringin has been shown to have a variety of biological, medicinal, and pharmacological effects. Naringin is hydrolyzed into rhamnose and prunin by the naringinase, which also possesses l-rhamnosidase activity. D-glucosidase subsequently catalyzes the hydrolysis of prunin into glucose and naringenin. Naringin is known for having anti-inflammatory, antioxidant, and tumor-fighting effects. Numerous test animals and cell lines have been used to correlate naringin exposure to asthma, hyperlipidemia, diabetes, cancer, hyperthyroidism, and osteoporosis. This study focused on the many documented actions of naringin in in-vitro and in-vivo experimental and preclinical investigations, as well as its prospective therapeutic advantages, utilizing the information that is presently accessible in the literature. In addition to its pharmacokinetic characteristics, naringin's structure, distribution, different extraction methods, and potential use in the cosmetic, food, pharmaceutical, and animal feed sectors were discussed.

Indexed as

FlavanonesFlavonesAnimalsAnti-Inflammatory AgentsGlycosidesAnti-Inflammatory AgentsFlavanonesFlavonesGlycosidesnaringinbioactive potentialextractionflavonoidnaringinpharmaceutical

Identifiers

PMID37570594
PMCPMC10419872
OpenAlexW4385251144

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.